Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gliadel

Astellas wins US approval for prostate cancer drug Xtandi

Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer

Bayer launches late-stage lung condition trial for ciprofloxacin

Study involves the use of Novartis’ T-326 inhaler

- PMLiVE

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

Amgen-Takeda’s ganitumab fails in pancreatic cancer study

Interim analysis shows no improvement in overall survival

Astellas to close US urology research facility

Work at Urogenix, North Carolina site will end by the end of the year

- PMLiVE

Interview: Yoshihiko Hatanaka, CEO and president, Astellas

The president and CEO of Astellas Pharma tells Jacky Law how he intends to steer the company through the current economic downturn

- PMLiVE

Interview: Ken Jones, Astellas Pharma Europe

The president and CEO of Astellas Pharma Europe talks to Liz Wells about beating the economic downturn and the experience of working for a Japanese company

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links